These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36656515)

  • 1. High-Throughput Expression of Inclusion Bodies on an Automated Platform.
    Kemmer A; Cai L; Cruz Bournazou MN; Neubauer P
    Methods Mol Biol; 2023; 2617():31-47. PubMed ID: 36656515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E.
    Ehgartner D; Sagmeister P; Langemann T; Meitz A; Lubitz W; Herwig C
    Appl Microbiol Biotechnol; 2017 Jul; 101(14):5603-5614. PubMed ID: 28429059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion Body Production in Fed-Batch and Continuous Cultivation.
    Kittler S
    Methods Mol Biol; 2023; 2617():87-102. PubMed ID: 36656518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scale-up bioprocess development for production of the antibiotic valinomycin in Escherichia coli based on consistent fed-batch cultivations.
    Li J; Jaitzig J; Lu P; Süssmuth RD; Neubauer P
    Microb Cell Fact; 2015 Jun; 14():83. PubMed ID: 26063334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF1 inclusion bodies: A QbD based process approach for efficient USP as well as early DSP unit operations.
    Metzger KFJ; Padutsch W; Pekarsky A; Kopp J; Voloshin AM; Kühnel H; Maurer M
    J Biotechnol; 2020 Mar; 312():23-34. PubMed ID: 32114153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.
    Patra AK; Mukhopadhyay R; Mukhija R; Krishnan A; Garg LC; Panda AK
    Protein Expr Purif; 2000 Mar; 18(2):182-92. PubMed ID: 10686149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed small-scale characterization and scale-up of active YFP inclusion body production with Escherichia coli induced by a tetrameric coiled coil domain.
    Lamm R; Jäger VD; Heyman B; Berg C; Cürten C; Krauss U; Jaeger KE; Büchs J
    J Biosci Bioeng; 2020 Jun; 129(6):730-740. PubMed ID: 32143998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant production of ESAT-6 antigen in thermoinducible Escherichia coli: the role of culture scale and temperature on metabolic response, expression of chaperones, and architecture of inclusion bodies.
    Restrepo-Pineda S; Bando-Campos CG; Valdez-Cruz NA; Trujillo-Roldán MA
    Cell Stress Chaperones; 2019 Jul; 24(4):777-792. PubMed ID: 31165436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and quantification of inclusion body formation in Escherichia coli by multi-parameter flow cytometry.
    Wållberg F; Sundström H; Ledung E; Hewitt CJ; Enfors SO
    Biotechnol Lett; 2005 Jul; 27(13):919-26. PubMed ID: 16091887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.
    Singh A; Upadhyay V; Upadhyay AK; Singh SM; Panda AK
    Microb Cell Fact; 2015 Mar; 14():41. PubMed ID: 25889252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.
    Kischnick S; Weber B; Verdino P; Keller W; Sanders EA; Anspach FB; Fiebig H; Cromwell O; Suck R
    Protein Expr Purif; 2006 Jun; 47(2):621-8. PubMed ID: 16495080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of inclusion bodies for bio-based products: curse or blessing?
    Slouka C; Kopp J; Spadiut O; Herwig C
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control of inclusion bodies in Escherichia coli.
    Jürgen B; Breitenstein A; Urlacher V; Büttner K; Lin H; Hecker M; Schweder T; Neubauer P
    Microb Cell Fact; 2010 May; 9():41. PubMed ID: 20509924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting protein refolding yields in a fed-batch and batch-refolding system.
    Mannall GJ; Titchener-Hooker NJ; Dalby PA
    Biotechnol Bioeng; 2007 Aug; 97(6):1523-34. PubMed ID: 17304557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a rapid high-efficiency scalable process for acetylated Sus scrofa cationic trypsin production from Escherichia coli inclusion bodies.
    Zhao M; Wu F; Xu P
    Protein Expr Purif; 2015 Dec; 116():120-6. PubMed ID: 26318238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of a recombinant phospholipase A2 in Escherichia coli using resonant acoustic mixing that improves oxygen transfer in shake flasks.
    Valdez-Cruz NA; Reynoso-Cereceda GI; Pérez-Rodriguez S; Restrepo-Pineda S; González-Santana J; Olvera A; Zavala G; Alagón A; Trujillo-Roldán MA
    Microb Cell Fact; 2017 Jul; 16(1):129. PubMed ID: 28743267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of N-terminal methionylation while increasing titer by lowering metabolic and protein production rates in E. coli auto-induced fed-batch fermentation.
    Xu J; Qian Y; Skonezny PM; You L; Xing Z; Meyers DS; Stankavage RJ; Pan SH; Li ZJ
    J Ind Microbiol Biotechnol; 2012 Aug; 39(8):1199-208. PubMed ID: 22526331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive evaluation of recombinant lactate dehydrogenase production from inclusion bodies.
    Igwe CL; Pauk JN; Müller DF; Jaeger M; Deuschitz D; Hartmann T; Spadiut O
    J Biotechnol; 2024 Jan; 379():65-77. PubMed ID: 38036002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes.
    Gnoth S; Simutis R; Lübbert A
    Appl Microbiol Biotechnol; 2010 Aug; 87(6):2047-58. PubMed ID: 20535469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.